COMP <GO>
CCCC vs RGNX // RSI-14 & 200D SMA MOMENTUM
C4 Therapeutics Inc. (NASDAQ) VS. REGENXBIO Inc. (NASDAQ) • 15-METRIC TALLY: CCCC 1
— RGNX 3
▲ RSI-14 & 200D SMA MOMENTUM LEADER: CCCC
LAST: $3.21 (-4.75%) • MKT CAP: $414.6M
rsi-technicals
56.6
LAST: $7.16 (-0.56%) • MKT CAP: $475.3M
rsi-technicals
46.6
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CCCC VS. RGNX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CCCC | RGNX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -24.46% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | -60.00% | 0.00 | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -60.00% | 0.00 | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 1.00% | 104.50% | -103.50 | RGNX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 0.20 | 0.00 | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 4/9 | -1.00 | RGNX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 56.6 | 46.6 | +10.00 | CCCC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $414.6M | $475.3M | -$60.7M | RGNX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CCCC REV | RGNX REV | CCCC GROSS % | RGNX GROSS % | CCCC FCF | RGNX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $35.9M | $170.4M | — | — | -$99.3M | -$126.4M |
| FY 2024 | $35.6M | $83.3M | — | 59.7% | -$65.3M | -$175.6M |
| FY 2023 | $20.8M | $90.2M | — | — | -$106.8M | -$218.4M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CCCC // BETA —
RGNX // BETA —